GTH Congress 2023 – 67th Annual Meeting of the Society of Thrombosis and Haemostasis Research – The patient as a benchmark最新文献

筛选
英文 中文
In vitro efficacy of direct oral anticoagulants in plasma from patients with liver cirrhosis 肝硬化患者血浆中直接口服抗凝剂的体外疗效观察
C. Pereira, MG Zermatten, M. Fraga, D. Bertaggia-Calderara, A. Aliotta, L. Veuthey, D. Shehwar, D. Moradpour, L. Alberio
{"title":"In vitro efficacy of direct oral anticoagulants in plasma from patients with liver cirrhosis","authors":"C. Pereira, MG Zermatten, M. Fraga, D. Bertaggia-Calderara, A. Aliotta, L. Veuthey, D. Shehwar, D. Moradpour, L. Alberio","doi":"10.1055/s-0042-1760483","DOIUrl":"https://doi.org/10.1055/s-0042-1760483","url":null,"abstract":"","PeriodicalId":217767,"journal":{"name":"GTH Congress 2023 – 67th Annual Meeting of the Society of Thrombosis and Haemostasis Research – The patient as a benchmark","volume":"22 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121112234","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The impact of Syk-inhibition on 5B9 monoclonal HIT antibody-mediated procoagulant platelet formation syk抑制对5B9单克隆HIT抗体介导的促凝血小板形成的影响
P. Wurmbäck, J. Zlámal, T. Bakchoul
{"title":"The impact of Syk-inhibition on 5B9 monoclonal HIT antibody-mediated procoagulant platelet formation","authors":"P. Wurmbäck, J. Zlámal, T. Bakchoul","doi":"10.1055/s-0042-1760618","DOIUrl":"https://doi.org/10.1055/s-0042-1760618","url":null,"abstract":"","PeriodicalId":217767,"journal":{"name":"GTH Congress 2023 – 67th Annual Meeting of the Society of Thrombosis and Haemostasis Research – The patient as a benchmark","volume":"136 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116330958","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Monitoring of unfractionated heparin in critical ill ICU patients: a prospective study comparing aPTT and point-of-care viscoelastic testing with IN /HI ratio to anti-Xa 危重重症ICU患者未分级肝素监测:一项比较aPTT和点护理粘弹性试验in /HI比抗xa的前瞻性研究
L. Heubner, A. Dietze, O. Tiebel, A. Güldner, O. Vicent, J. Beyer-Westendorf, T. Koch, P. Spieth
{"title":"Monitoring of unfractionated heparin in critical ill ICU patients: a prospective study comparing aPTT and point-of-care viscoelastic testing with IN /HI ratio to anti-Xa","authors":"L. Heubner, A. Dietze, O. Tiebel, A. Güldner, O. Vicent, J. Beyer-Westendorf, T. Koch, P. Spieth","doi":"10.1055/s-0042-1760501","DOIUrl":"https://doi.org/10.1055/s-0042-1760501","url":null,"abstract":"","PeriodicalId":217767,"journal":{"name":"GTH Congress 2023 – 67th Annual Meeting of the Society of Thrombosis and Haemostasis Research – The patient as a benchmark","volume":"3 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124132542","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adults with severe or moderately severe haemophilia B receiving etranacogene dezaparvovec in the HOPE-B phase 3 trial experience a stable increase in mean Factor IX activity levels and durable haemostatic protection after 24 months’ follow-up 在HOPE-B iii期试验中,接受dezaparvovec的重度或中度血友病B成人患者在24个月的随访后,平均因子IX活性水平稳定增加,并具有持久的止血保护作用
W. S. Pipe, WG F Leebeek, M. Recht, S. Key, S. Lattimore, G. Castaman, M. Coppens, D. Cooper, R. Gut, S. Slawka, S. Verweij, R. Dolmetsch, Y. Li, P. Monahan, W. Miesbach
{"title":"Adults with severe or moderately severe haemophilia B receiving etranacogene dezaparvovec in the HOPE-B phase 3 trial experience a stable increase in mean Factor IX activity levels and durable haemostatic protection after 24 months’ follow-up","authors":"W. S. Pipe, WG F Leebeek, M. Recht, S. Key, S. Lattimore, G. Castaman, M. Coppens, D. Cooper, R. Gut, S. Slawka, S. Verweij, R. Dolmetsch, Y. Li, P. Monahan, W. Miesbach","doi":"10.1055/s-0042-1760523","DOIUrl":"https://doi.org/10.1055/s-0042-1760523","url":null,"abstract":"","PeriodicalId":217767,"journal":{"name":"GTH Congress 2023 – 67th Annual Meeting of the Society of Thrombosis and Haemostasis Research – The patient as a benchmark","volume":"24 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"125430162","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The impact of enhanced platelet turnover on platelet reactivity in healthy humans 增强血小板周转对健康人血小板反应性的影响
L. S. Schwarz, M. Wolff, A. Greinacher, S. Handtke, T. Thiele
{"title":"The impact of enhanced platelet turnover on platelet reactivity in healthy humans","authors":"L. S. Schwarz, M. Wolff, A. Greinacher, S. Handtke, T. Thiele","doi":"10.1055/s-0042-1760593","DOIUrl":"https://doi.org/10.1055/s-0042-1760593","url":null,"abstract":"","PeriodicalId":217767,"journal":{"name":"GTH Congress 2023 – 67th Annual Meeting of the Society of Thrombosis and Haemostasis Research – The patient as a benchmark","volume":"118 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124544427","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Safety and efficacy of recombinant Factor IX fusion protein (rIX-FP) in previously untreated patients with haemophilia B 重组因子IX融合蛋白(rIX-FP)在未经治疗的B型血友病患者中的安全性和有效性
R. Lemons, M. Wang, J. Curtin, M. L. Lepatan, C. Male, F. Peyvandi, M. von Depka, R. Wang, W. McKeand, W. Seifert, J. Oldenburg
{"title":"Safety and efficacy of recombinant Factor IX fusion protein (rIX-FP) in previously untreated patients with haemophilia B","authors":"R. Lemons, M. Wang, J. Curtin, M. L. Lepatan, C. Male, F. Peyvandi, M. von Depka, R. Wang, W. McKeand, W. Seifert, J. Oldenburg","doi":"10.1055/s-0042-1760518","DOIUrl":"https://doi.org/10.1055/s-0042-1760518","url":null,"abstract":"","PeriodicalId":217767,"journal":{"name":"GTH Congress 2023 – 67th Annual Meeting of the Society of Thrombosis and Haemostasis Research – The patient as a benchmark","volume":"87 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115862995","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring red blood cells as a novel tolerogenic approach for Factor VIII inhibitors employing immuno-dominant FVIII derived peptides presented on MHC class II 利用MHC II类上呈现的免疫显性FVIII衍生肽,探索红细胞作为因子VIII抑制剂的新耐受性途径
M. Miranda, E. Brandsma, P. Kaijen, F. V. van Alphen, R. van Bruggen, K. Fijnvandraat, S. Lacroix-Desmazes, J. Voorberg
{"title":"Exploring red blood cells as a novel tolerogenic approach for Factor VIII inhibitors employing immuno-dominant FVIII derived peptides presented on MHC class II","authors":"M. Miranda, E. Brandsma, P. Kaijen, F. V. van Alphen, R. van Bruggen, K. Fijnvandraat, S. Lacroix-Desmazes, J. Voorberg","doi":"10.1055/s-0042-1760520","DOIUrl":"https://doi.org/10.1055/s-0042-1760520","url":null,"abstract":"","PeriodicalId":217767,"journal":{"name":"GTH Congress 2023 – 67th Annual Meeting of the Society of Thrombosis and Haemostasis Research – The patient as a benchmark","volume":"50 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130330992","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Anti-PF4 antibodies after SARS-CoV-2 vaccines: long term follow-up SARS-CoV-2疫苗后的抗pf4抗体:长期随访
G. Uzun, K. Althaus, B. Luz, M. Wolf, H. Henkes, T. Bakchoul
{"title":"Anti-PF4 antibodies after SARS-CoV-2 vaccines: long term follow-up","authors":"G. Uzun, K. Althaus, B. Luz, M. Wolf, H. Henkes, T. Bakchoul","doi":"10.1055/s-0042-1760583","DOIUrl":"https://doi.org/10.1055/s-0042-1760583","url":null,"abstract":"","PeriodicalId":217767,"journal":{"name":"GTH Congress 2023 – 67th Annual Meeting of the Society of Thrombosis and Haemostasis Research – The patient as a benchmark","volume":"24 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126049053","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Investigating the interaction of circulating von Willebrand factor with polymorphonuclear leukocytes ex vivo 体外研究循环血管性血友病因子与多形核白细胞的相互作用
H. Yadegari, A. Kuanyshbek, NS Hamedani, J. Oldenburg
{"title":"Investigating the interaction of circulating von Willebrand factor with polymorphonuclear leukocytes ex vivo","authors":"H. Yadegari, A. Kuanyshbek, NS Hamedani, J. Oldenburg","doi":"10.1055/s-0042-1760454","DOIUrl":"https://doi.org/10.1055/s-0042-1760454","url":null,"abstract":"","PeriodicalId":217767,"journal":{"name":"GTH Congress 2023 – 67th Annual Meeting of the Society of Thrombosis and Haemostasis Research – The patient as a benchmark","volume":"20 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127746244","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Durability of bleeding protection and Factor IX activity in individuals with and without adeno-associated virus serotype 5 neutralising antibodies (Titres <1:700) in the phase 3 HOPE-B trial of etranacogene dezaparvovec gene therapy for haemophilia B 在dezaparvovec基因治疗B型血友病的3期HOPE-B试验中,携带和不携带腺相关病毒血清5型中和抗体(滴度<1:700)的个体的出血保护持久性和因子IX活性
W. S. Pipe, WG F Leebeek, M. Recht, S. Key, S. Lattimore, G. Castaman, D. Cooper, S. Verweij, R. Dolmetsch, J. Tarrant, Y. Li, E. P. Monahan, W. Miesbach
{"title":"Durability of bleeding protection and Factor IX activity in individuals with and without adeno-associated virus serotype 5 neutralising antibodies (Titres <1:700) in the phase 3 HOPE-B trial of etranacogene dezaparvovec gene therapy for haemophilia B","authors":"W. S. Pipe, WG F Leebeek, M. Recht, S. Key, S. Lattimore, G. Castaman, D. Cooper, S. Verweij, R. Dolmetsch, J. Tarrant, Y. Li, E. P. Monahan, W. Miesbach","doi":"10.1055/s-0042-1760524","DOIUrl":"https://doi.org/10.1055/s-0042-1760524","url":null,"abstract":"","PeriodicalId":217767,"journal":{"name":"GTH Congress 2023 – 67th Annual Meeting of the Society of Thrombosis and Haemostasis Research – The patient as a benchmark","volume":"57 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127117426","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信